CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is…
Biotechnology
US, Houston [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
CNS Pharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
CNS Pharmaceuticals, Inc. has no acquisition track records yet.